Real world utilization of REGEN-COV2 at a community hospital

INTRODUCTION: Monoclonal antibodies received an Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration for the outpatient treatment of mild to moderate coronavirus disease 2019 (COVID-19). REGN-COV2, casirivimab and imdevimab, has been shown to decrease the viral load and hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Ash, Jordan, Leavitt, Rachael, Dietrich, Tyson, Schritter, Sarah, Wells, James, Santarelli, Anthony, Ashurst, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313789/
https://www.ncbi.nlm.nih.gov/pubmed/34364110
http://dx.doi.org/10.1016/j.ajem.2021.07.050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313789/
https://www.ncbi.nlm.nih.gov/pubmed/34364110
http://dx.doi.org/10.1016/j.ajem.2021.07.050

Ejemplares similares